Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
SEC Accession No. 0001104659-06-031292
Filing Date
2006-05-05
Accepted
2006-05-04 19:35:55
Documents
2
Group Members
DORSET MANAGEMENT CORPORATION

Document Format Files

Seq Description Document Type Size
1 AMENDMENT a06-8856_4sc13da.htm SC 13D/A 308464
2 EX-99 a06-8856_4ex99da.htm EX-99.A 7507
  Complete submission text file 0001104659-06-031292.txt   317929
Mailing Address 5800 PARK OF COMMERCE BLVD NW STE 322 BOCA RATON FL 33487
Business Address 5800 PARK OF COMMERCE BLVD N W STE 322 BOCA RATON FL 33487 5619895800
NABI BIOPHARMACEUTICALS (Subject) CIK: 0000072444 (see all company filings)

EIN.: 591212264 | State of Incorp.: DE | Fiscal Year End: 1225
Type: SC 13D/A | Act: 34 | File No.: 005-31596 | Film No.: 06810277
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address 485 UNDERHILL BLVD STE 205 SYOSSET NY 11791-3419
Business Address
KNOTT DAVID M (Filed by) CIK: 0000808722 (see all company filings)

Type: SC 13D/A